Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis.

Dahlqvist, Géraldine;Gaouar, Farid;Carrat, Fabrice;Meurisse, Sofia;Corpechot, Christophe;et.al.
(2017) Hepatology — Vol. 65, n° 1, p. 152-163 (2017)

Files

document.pdf
  • Restricted Access
  • Adobe PDF
  • 469 KB

Details

Authors
  • Author
  • Gaouar, Farid
    Author
  • Carrat, Fabrice
    Author
  • Meurisse, Sofia
    Author
  • Corpechot, Christophe
    Author
Show more
Abstract
The prevalence, clinical characteristics, and outcomes of patients with antimitochondrial antibodies (AMAs), but no clinical evidence of primary biliary cholangitis (PBC), are largely unknown. A prospective study of AMA incidence was conducted through a nation-wide network of 63 French immunology laboratories. Clinical data from 720 of 1,318 AMA-positive patients identified in 1 year were collected. Patients were categorized as either newly diagnosed with PBC (n = 275), previously diagnosed with PBC (n = 216), or with nonestablished diagnosis of PBC (n = 229). The latter group was specifically evaluated. Follow-up data were collected for up to 7 years after detection of AMAs. Prevalence of AMA-positive patients without evidence of PBC was 16.1 per 100,000. These patients had the following characteristics: 78% female; median age 58 years; median AMA titer 1:160; extrahepatic autoimmune disorders 46%; normal serum alkaline phosphatases (ALP) 74%; ALP above 1.5 times the upper limit of normal 13%; and cirrhosis 6%. Compared to those newly diagnosed with PBC, the patients were slightly younger, had lower AMA titers, and lower sex-ratio imbalance. Among the patients with normal ALP and no evidence of cirrhosis, the 5-year incidence rate of PBC was 16%. Whereas no patients died from PBC, the 5-year survival rate was 75%, as compared to 90% in a control, standardized population matched for age and sex (P < 0.05).
Affiliations

Citations

Dahlqvist, G., Gaouar, F., Carrat, F., Meurisse, S., Chazouillères, O., Poupon, R., Johanet, C., & Corpechot, C. (2017). Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis. Hepatology, 65(1), 152-163. https://doi.org/10.1002/hep.28859 (Original work published 2017)